Pancreatic Cancer Research

ResearcherRegional Centre for BiotechnologyNo recent work listed

Aliva Prity Minz

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-9878-1743; OpenAlex author ID A5056869022. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
6
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper

Papers 2

  1. Statins abrogate gemcitabine-induced PD-L1 expression in pancreatic cancer-associated fibroblasts and cancer cells with improved therapeutic outcome. Co-author DOI 10.1007/s00262-023-03562-9↗
  2. Fluvastatin sensitizes pancreatic cancer cells toward radiation therapy and suppresses radiation- and/or TGF-β-induced tumor-associated fibrosis. Co-author DOI 10.1038/s41374-021-00690-7↗

Closest collaborators

The 6 strongest of 6 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Deepti Parida · 2 shared papers, 2022–2023 · strength 0.33
  2. Debasish Mohapatra · 2 shared papers, 2022–2023 · strength 0.33
  3. Shantibhusan Senapati · 2 shared papers, 2022–2023 · strength 0.33
  4. Madhuri Dutta · 1 shared paper, 2023 · strength 0.18
  5. Voddu Suresh · 1 shared paper, 2022 · strength 0.16
  6. Biswajit Das · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.